trimethylamine has been researched along with Apoplexy in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although trimethylamine-N-oxide (TMAO) shows a notable correlation with cardiovascular disease, its association with acute ischemic stroke (AIS) remains uncertain and necessitates further investigation." | 9.41 | The relationship between trimethylamine-N-oxide and the risk of acute ischemic stroke: A dose‒response meta-analysis. ( Duan, Y; Guo, Z; Hong, Y; Li, Y; Liu, N; Sun, Z; Xu, Q; Yang, K, 2023) |
| " We aimed to evaluate whether residual risk of recurrent stroke of TMAO and its precursor choline remain among patients who received dual-antiplatelet therapy and intensive lipid-lowering therapy and with a low inflammation level (high-sensitivity C-reactive protein <2 mg/L on admission)." | 8.12 | Residual Risk of Trimethylamine-N-Oxide and Choline for Stroke Recurrence in Patients With Intensive Secondary Therapy. ( Cheng, A; Jiang, X; Jin, A; Li, H; Li, K; Lin, J; Meng, X; Wang, Y; Xu, J; Xue, J; Zhao, M; Zheng, L, 2022) |
| "Although trimethylamine-N-oxide (TMAO) shows a notable correlation with cardiovascular disease, its association with acute ischemic stroke (AIS) remains uncertain and necessitates further investigation." | 5.41 | The relationship between trimethylamine-N-oxide and the risk of acute ischemic stroke: A dose‒response meta-analysis. ( Duan, Y; Guo, Z; Hong, Y; Li, Y; Liu, N; Sun, Z; Xu, Q; Yang, K, 2023) |
| "There is increasing evidence for the association of trimethylamine-N-oxide (TMAO) with cognitive impairment after minor stroke or transient ischemic attack (TIA)." | 4.31 | Association between plasma trimethylamine-N-oxide and cognitive impairment in patients with transient ischemic attack. ( Bao, Y; Huang, D; Jiang, L; Qv, S; Wang, J; Wang, L; Xu, G; Yang, J; Zhan, X, 2023) |
| " We aimed to evaluate whether residual risk of recurrent stroke of TMAO and its precursor choline remain among patients who received dual-antiplatelet therapy and intensive lipid-lowering therapy and with a low inflammation level (high-sensitivity C-reactive protein <2 mg/L on admission)." | 4.12 | Residual Risk of Trimethylamine-N-Oxide and Choline for Stroke Recurrence in Patients With Intensive Secondary Therapy. ( Cheng, A; Jiang, X; Jin, A; Li, H; Li, K; Lin, J; Meng, X; Wang, Y; Xu, J; Xue, J; Zhao, M; Zheng, L, 2022) |
| "Increased levels of lactic acid, pyruvate, and TMAO may be related to the pathophysiological changes in the minor ischaemic stroke population." | 4.12 | Related factors based on non-targeted metabolomics methods in minor ischaemic stroke. ( Chen, C; Ding, L; Guo, J; Liu, H; Ma, Y; Qiao, X; Wang, J; Wang, M; Yang, T; Zhao, S, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 7 (87.50) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, H | 1 |
| Yao, G | 1 |
| Xue, J | 1 |
| Xu, J | 1 |
| Zhao, M | 1 |
| Jin, A | 1 |
| Cheng, A | 1 |
| Jiang, X | 1 |
| Li, K | 1 |
| Lin, J | 1 |
| Meng, X | 1 |
| Li, H | 1 |
| Zheng, L | 1 |
| Wang, Y | 1 |
| Chen, C | 1 |
| Qiao, X | 1 |
| Guo, J | 1 |
| Yang, T | 1 |
| Wang, M | 1 |
| Ma, Y | 1 |
| Zhao, S | 1 |
| Ding, L | 1 |
| Liu, H | 1 |
| Wang, J | 2 |
| Lemaitre, RN | 2 |
| Jensen, PN | 2 |
| Mozaffarian, D | 2 |
| Wang, L | 1 |
| Zhan, X | 1 |
| Jiang, L | 1 |
| Xu, G | 1 |
| Bao, Y | 1 |
| Qv, S | 1 |
| Yang, J | 1 |
| Huang, D | 1 |
| Wang, Z | 1 |
| Fretts, AM | 1 |
| Sitlani, CM | 1 |
| Nemet, I | 1 |
| Sotoodehnia, N | 1 |
| de Oliveira Otto, MC | 1 |
| Zhu, W | 1 |
| Budoff, M | 1 |
| Longstreth, WT | 1 |
| Psaty, BM | 1 |
| Siscovick, DS | 1 |
| Hazen, SL | 1 |
| Hong, Y | 1 |
| Sun, Z | 1 |
| Liu, N | 1 |
| Yang, K | 1 |
| Li, Y | 1 |
| Xu, Q | 1 |
| Guo, Z | 1 |
| Duan, Y | 1 |
| Tarchichi, T | 1 |
| Wong, K | 1 |
| Fisher, MM | 1 |
| Palomo, P | 1 |
| Zapata, F | 1 |
| Bawle, EV | 1 |
2 reviews available for trimethylamine and Apoplexy
| Article | Year |
|---|---|
Significant correlation between the gut microbiota-derived metabolite trimethylamine-N-oxide and the risk of stroke: evidence based on 23 observational studies.
Topics: Gastrointestinal Microbiome; Humans; Methylamines; Oxides; Risk Factors; Stroke | 2023 |
The relationship between trimethylamine-N-oxide and the risk of acute ischemic stroke: A dose‒response meta-analysis.
Topics: Humans; Ischemic Stroke; Methylamines; Oxides; Stroke | 2023 |
1 trial available for trimethylamine and Apoplexy
| Article | Year |
|---|---|
Plasma Trimethylamine-
Topics: Aged; Atherosclerosis; Female; Humans; Ischemic Stroke; Methylamines; Oxides; Prospective Studies; R | 2023 |
5 other studies available for trimethylamine and Apoplexy
| Article | Year |
|---|---|
Residual Risk of Trimethylamine-N-Oxide and Choline for Stroke Recurrence in Patients With Intensive Secondary Therapy.
Topics: C-Reactive Protein; Choline; Humans; Inflammation; Lipids; Methylamines; Oxides; Platelet Aggregatio | 2022 |
Related factors based on non-targeted metabolomics methods in minor ischaemic stroke.
Topics: Biomarkers; Blood Glucose; Brain Ischemia; C-Reactive Protein; Homocysteine; Humans; Hypertension; I | 2022 |
Letter to the editor about published meta-analysis of TMAO and stroke.
Topics: Gastrointestinal Microbiome; Humans; Oxides; Stroke | 2023 |
Association between plasma trimethylamine-N-oxide and cognitive impairment in patients with transient ischemic attack.
Topics: Aged; Cognitive Dysfunction; Humans; Ischemic Attack, Transient; Male; Oxides; Retrospective Studies | 2023 |
Index of suspicion.
Topics: Adolescent; Anticoagulants; Diagnosis, Differential; Diet Therapy; Embolism, Paradoxical; Female; Ga | 2013 |